On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias
- PMID: 193526
- DOI: 10.1016/0021-9150(77)90127-7
On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias
Abstract
In Type V hyperlipoproteinaemia the concentration of LDL and HDL cholesterol is low. When the hypertriglyceridaemia is normalized, either by diet or micotinic acid, both LDL and HDL increase. In Type IV hyperlipoproteinaemia both LDL and HDL cholesterol decrease with increasing VLDL levels. During treatment of Type IV the change in LDL cholesterol is linearly related to the pretreatment LDL concentration so that higher LDL levels will fall and the lower will rise. HDL levels will also rise. The fall in VLDL during treatment is rapid and the rise in LDL also occurs rapidly indicating a relationship between these two reciprocal changes. HDL cholesterol, however, however, remains constant some time after VLDL has reached its lowest level and the rise occurs later indicating another mechanism than for LDL. These changes in the three major lipoprotein classes deserve clinical attention. While both the fall in VLDL and the rise in HDL may be benefical from the point of view of atherosclerosis the rise in LDL may be harmful. These is at present no way to evaluate the effect of these complex changes. However, these findings stress the imporance of considering changes in lipoprotein levels and not only in total serum triglycerides and cholesterol during treatment of hyperlipoproteinaemia.
Similar articles
-
[Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].Klin Wochenschr. 1977 Aug 15;55(16):791-4. doi: 10.1007/BF01651267. Klin Wochenschr. 1977. PMID: 198601 German.
-
Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.Am J Med. 1977 Dec;63(6):1001-9. doi: 10.1016/0002-9343(77)90555-1. Am J Med. 1977. PMID: 204188 No abstract available.
-
One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.Atherosclerosis. 1978 Dec;31(4):429-33. doi: 10.1016/0021-9150(78)90138-7. Atherosclerosis. 1978. PMID: 215175
-
Treatment of hyperlipidemia.N Engl J Med. 1974 Jun 6;290(23):1295-301. doi: 10.1056/NEJM197406062902306. N Engl J Med. 1974. PMID: 4363888 Review. No abstract available.
-
[Familial hyperlipoproteinemia type III].Dtsch Med Wochenschr. 1976 Oct 29;101(44):1612-9. doi: 10.1055/s-0028-1104313. Dtsch Med Wochenschr. 1976. PMID: 185039 Review. German. No abstract available.
Cited by
-
Specific lipid lowering therapy in the management of diabetes.Postgrad Med J. 1991 Oct;67(792):947-52. doi: 10.1136/pgmj.67.792.947. Postgrad Med J. 1991. PMID: 1758809 Free PMC article. Review. No abstract available.
-
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.Eur J Clin Pharmacol. 1991;40(1):33-41. doi: 10.1007/BF00315136. Eur J Clin Pharmacol. 1991. PMID: 2060543
-
Mechanism of action of gemfibrozil on lipoprotein metabolism.J Clin Invest. 1985 May;75(5):1702-12. doi: 10.1172/JCI111879. J Clin Invest. 1985. PMID: 3923042 Free PMC article.
-
Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism.J Clin Invest. 1979 May;63(5):858-67. doi: 10.1172/JCI109385. J Clin Invest. 1979. PMID: 221531 Free PMC article.
-
Cholesteryl ester and triacylglycerol fatty acids in type V hyperlipidemia.Lipids. 1979 Jul;14(7):691-4. doi: 10.1007/BF02533457. Lipids. 1979. PMID: 225633
MeSH terms
Substances
LinkOut - more resources
Full Text Sources